Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients

被引：0
|
作者：
Jean Claude Alvarez
Pierre Moine
Benjamin Davido
Isabelle Etting
Djillali Annane
Islam Amine Larabi
Nicolas Simon
机构：
[1] Raymond Poincaré Hospital,Department of Pharmacology and Toxicology, Paris
[2] AP-HP,Saclay University (Versailles Saint
[3] Hôpital Raymond Poincaré,Quentin
[4] AP-HP,en
[5] Raymond Poincaré hospital,Yvelines), Inserm U
[6] AP-HP,1173, FHU Sepsis
[7] Raymond Poincaré hospital,Laboratoire de Pharmacologie
[8] AP-HP,Toxicologie, Université de Versailles Saint
[9] Aix-Marseille University,Quentin
来源：
European Journal of Clinical Pharmacology | 2021年 / 77卷
关键词：
Lopinavir; Pharmacokinetics; Covid-19;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：389 / 397
页数：8
相关论文
共 50 条
  • [1] Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients
    Alvarez, Jean Claude
    Moine, Pierre
    Davido, Benjamin
    Etting, Isabelle
    Annane, Djillali
    Larabi, Islam Amine
    Simon, Nicolas
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (03) : 389 - 397
  • [2] Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19)
    Schoergenhofer, Christian
    Jilma, Bernd
    Stimpfl, Thomas
    Karolyi, Mario
    Zoufaly, Alexander
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (08) : 670 - +
  • [3] Lopinavir pharmacokinetics in COVID-19 patients
    Gregoire, Matthieu
    Le Turnier, Paul
    Gaborit, Benjamin J.
    Veyrac, Gwenaelle
    Lecomte, Raphael
    Boutoille, David
    Canet, Emmanuel
    Imbert, Berthe-Marie
    Bellouard, Ronan
    Raffi, Francois
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (09) : 2702 - 2704
  • [4] Remdesivir versus ritonavir/lopinavir in COVID-19 patients
    Antonio Vitiello
    Francesco Ferrara
    Irish Journal of Medical Science (1971 -), 2021, 190 : 1249 - 1250
  • [5] Risk of bradycardia with lopinavir/ritonavir in COVID-19 patients
    Reactions Weekly, 2020, 1814 (1) : 9 - 9
  • [6] Remdesivir versus ritonavir/lopinavir in COVID-19 patients
    Vitiello, Antonio
    Ferrara, Francesco
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (03) : 1249 - 1250
  • [7] Lopinavir–ritonavir in severe COVID-19
    Hannah Stower
    Nature Medicine, 2020, 26 : 465 - 465
  • [8] Letter to the Editor: Pharmacokinetics of Lopinavir/Ritonavir in Hospitalized Patients with COVID-19 Not Requiring Critical Care
    MacGowan, Alasdair
    Hamilton, Fergus
    Bayliss, Mark
    Read, Liam
    Attwood, Marie
    Noel, Alan
    Albur, Maha
    Grier, Sally
    Morley, Anna
    Arnold, David
    Maskell, Nicholas
    MICROBIAL DRUG RESISTANCE, 2022, 28 (05) : 611 - 612
  • [9] Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients
    Le, Minh Patrick
    Jaquet, Pierre
    Patrier, Juliette
    Wicky, Paul-Henri
    Le Hingrat, Quentin
    Veyrier, Marc
    Kauv, Juliette
    Sonneville, Romain
    Visseaux, Benoit
    Laouenan, Cedric
    Bouadma, Lila
    Descamps, Diane
    de Montmollin, Etienne
    Peytavin, Gilles
    Timsit, Jean-Francois
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (09) : 2657 - 2660
  • [10] Lopinavir-Ritonavir and Liver Involvement in Patients With COVID-19
    Lv, Xiu-He
    Yang, Jin-Lin
    Deng, Kai
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (05): : 1099 - 1099
12345